241 related articles for article (PubMed ID: 31418338)
1. On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).
Pira E; Boffetta P; Ciocan C
Tumori; 2019 Aug; 105(4):359-360. PubMed ID: 31418338
[No Abstract] [Full Text] [Related]
2. On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).
Barbieri PG
Tumori; 2019 Aug; 105(4):361-362. PubMed ID: 30592233
[No Abstract] [Full Text] [Related]
3. Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Nakajima Y; Kuribayashi K; Ishigaki H; Tada A; Negi Y; Minami T; Takahashi R; Doi H; Kitajima K; Yokoi T; Kijima T
Cancer Invest; 2020 Jul; 38(6):356-364. PubMed ID: 32468861
[TBL] [Abstract][Full Text] [Related]
4. [Application and evaluation of EFEMP1 in differential diagnosis of malignant mesothelioma and poorly differentiated adenocarcinoma].
Wang CS; Meng FQ; Li Q; Wang ZY; Tian L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1269-1271. PubMed ID: 38058046
[No Abstract] [Full Text] [Related]
5. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
6. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
7. Melan A (A103) is not a marker of mesothelioma.
Ordóñez NG; Shen SS; Zenali M; Deavers MT
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):181-4. PubMed ID: 22820661
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Popat S; Baas P; Faivre-Finn C; Girard N; Nicholson AG; Nowak AK; Opitz I; Scherpereel A; Reck M;
Ann Oncol; 2022 Feb; 33(2):129-142. PubMed ID: 34861373
[No Abstract] [Full Text] [Related]
9. Presence of malignant mesothelial cells in the sputum.
Choi YH; Park KY; Ryoo BY; Na II; Yang SH; Koh JS; Kim CH; Lee JC
Intern Med; 2008; 47(1):57-60. PubMed ID: 18176007
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
Husain AN; Colby T; Ordonez N; Krausz T; Attanoos R; Beasley MB; Borczuk AC; Butnor K; Cagle PT; Chirieac LR; Churg A; Dacic S; Fraire A; Galateau-Salle F; Gibbs A; Gown A; Hammar S; Litzky L; Marchevsky AM; Nicholson AG; Roggli V; Travis WD; Wick M;
Arch Pathol Lab Med; 2013 May; 137(5):647-67. PubMed ID: 22929121
[TBL] [Abstract][Full Text] [Related]
11. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
Martínez-Rivera V; Negrete-García MC; Ávila-Moreno F; Ortiz-Quintero B
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462963
[TBL] [Abstract][Full Text] [Related]
12. Two malignancies or an unusual presentation of a pleural malignancy?
Knipscheer BJ; Kromontono RC; de Bruin PC; van Strijen MJ; Herder GJ
Lung Cancer; 2013 Aug; 81(2):306-7. PubMed ID: 23684920
[TBL] [Abstract][Full Text] [Related]
13. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
Gee GV; Koestler DC; Christensen BC; Sugarbaker DJ; Ugolini D; Ivaldi GP; Resnick MB; Houseman EA; Kelsey KT; Marsit CJ
Int J Cancer; 2010 Dec; 127(12):2859-69. PubMed ID: 21351265
[TBL] [Abstract][Full Text] [Related]
14. [Medical assessment of pleural thickening].
Downer NJ; Ali NJ; Au-Yong IT
Praxis (Bern 1994); 2013 Jun; 102(12):741-5. PubMed ID: 23735766
[No Abstract] [Full Text] [Related]
15. Perineural spread of malignant mesothelioma with spinal intramedullary involvement.
Tanwar M; Simone CB; Newman S; Cengel K; Yu GH; Melhem ER; Mohan S
Clin Neurol Neurosurg; 2014 May; 120():116-9. PubMed ID: 24731589
[No Abstract] [Full Text] [Related]
16. Accurate diagnosis of mesothelioma: more important than ever.
Allen TC
Arch Pathol Lab Med; 2013 May; 137(5):601-2. PubMed ID: 23627448
[No Abstract] [Full Text] [Related]
17. Prognostic factors in malignant pleural mesothelioma.
Davidson B
Hum Pathol; 2015 Jun; 46(6):789-804. PubMed ID: 25824607
[TBL] [Abstract][Full Text] [Related]
18. Amplification of MET in a Patient with Malignant Pleural Mesothelioma.
Varesano S; Salvi S; Boccardo S; Ravetti JL; Ferro P; Canessa PA; Fedeli F; Pistillo MP; Roncella S
J Thorac Oncol; 2015 Oct; 10(10):e103-4. PubMed ID: 26398828
[No Abstract] [Full Text] [Related]
19. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
Yuasa H; Tomoyasu M
Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-tumor mimicking indwelling pleural catheter tract metastasis in mesothelioma.
Shrestha RL; Wood BA; Lee YC
J Bronchology Interv Pulmonol; 2014 Oct; 21(4):350-2. PubMed ID: 25321457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
